ArticleVaccine2025
Assessing factors associated with one-year antibody waning in participants with repeated influenza vaccinations: A six-year cohort study.
Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe long-term effects of host factors on vaccine-induced immune responses have been widely studied, but limited research has explored the waning of antibody levels after repeated influenza vaccinations in longitudinal settings.
methodsThis study included 330 participants (584 observations), who received the standard-dose influenza vaccine across multiple seasons (≥2) from 2016 to 2022. Host demographics were collected prospectively, and serum samples were obtained pre- and post-vaccination each season. Linear mixed-effects models using restricted maximum likelihood (REML) were applied to evaluate waning scores, defined as the rate of decline in hemagglutination inhibition (HAI) composite scores, while accounting for demographic factors.
resultsHigher BMI was significantly associated with greater antibody decline in the teenager subgroup, whereas no significant association was observed in adults or the elderly. In teenagers, age was negatively associated with antibody decline, whereas in adults (19-64 years), age was positively associated. Higher post-vaccination titers and greater pre-post vaccination boost scores were linked to increased antibody waning across all age groups, with significant effects observed in teenagers and adults but not the elderly. The differences by study influenza season influenced antibody waning in adults and the overall cohort but showed no significant effect in teenagers or the elderly (65+ years). Sex was not significantly associated with antibody waning in any age group.
conclusionsThis study highlights multiple factors, including age, BMI, vaccination history, and immune response characteristics, that contribute to the waning of antibodies after repeated influenza vaccinations. These findings underscore the importance of personalized vaccination strategies to maintain long-term immunity and enhance vaccine effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.